Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C

Journal of Gastroenterology

Volumn 45, Issue 9, 2010, Pages 960-967

  Tokushige, Katsutoshi ^a   Hashimoto, Etsuko ^a   Yatsuji, Satoru ^a   Tobari, Maki ^a   Taniai, Makiko ^a   Torii, Nobuyuki ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; Natural history; Nonalcoholic steatohepatitis; Recurrence

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CAUSAL ATTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEPATITIS C; HEPATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER SURGERY; MALE; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RECURRENCE RISK; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 77956927733     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0237-1     Document Type: Article

References (26)

1. HM El-Serag RK Lenhard 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2557 2576 1:CAS:528: DC%2BD2sXnvFOgsrw%3D 10.1053/j.gastro.2007.04.061 17570226 (Pubitemid 46890874)
2. Health and Welfare Statistics. Health and Welfare Statistics Association. The analysis of health in Japan. J Health Welf Stat. 2004;51:35-76.
3. Kudo M, Arii S, Ikari I, Okazaki M, Okita K, Omata M, et al. The nationwide report registered every 2 years by the Liver Cancer Study Group of Japan (in Japanese with English abstract). Kanzo 2007;48:117-140.
4. M Shimada E Hashimoto M Taniai K Hasegawa H Okuda N Hayashi 2002 Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis J Hepatol 37 154 160 10.1016/S0168-8278(02)00099-5 12076877 (Pubitemid 34713069)
5. E Hashimoto S Yatsuji M Tobari M Taniai N Torii K Tokushige, et al. 2009 Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis J Gastroenterol 44 89 95 10.1007/s00535-008-2262-x 19148800
6. S Yatsuji E Hashimoto M Tobari M Taniai K Tokushige K Shiratori 2009 Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C J Gastroenterol Hepatol 24 248 254 1:CAS:528:DC%2BD1MXjslKksr0%3D 10.1111/j.1440-1746.2008.05640.x 19032450
7. M Ekstedt LE Franzen UL Mathiensen L Thorelius M Holmqvist G Bodemar, et al. 2006 Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 802 805 10.1002/hep.21327 (Pubitemid 46489550)
8. AJ Sanyal C Banas C Sargeant VA Luketic RK Sterling RT Stravitz, et al. 2006 Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C Hepatology 43 682 689 10.1002/hep.21103 16502396
9. V Ratziu L Bonyhay V Di Martino F Charlotte L Cavallaro MH Sayegh-Tainturier, et al. 2002 Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis Hepatology 35 1485 1493 10.1053/jhep.2002.33324 12029634 (Pubitemid 34966903)
10. AJ Sanyal American Gastroenterological Association 2002 AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 1705 1725 10.1053/gast.2002.36572 12404245
11. American Gastroenterological Association 2002 American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease Gastroenterology 123 1702 1704 10.1053/gast.2002.36569
12. BA Neuschwander-Tetri SH Caldwell 2003 Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 1202 1219 10.1053/jhep.2003.50193 12717402 (Pubitemid 36538699)
13. DE Kleiner EM Brunt M Van Natta C Behling MJ Contos OW Cummings, et al. 2005 Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 1313 1321 10.1002/hep.20701 15915461 (Pubitemid 40770284)
14. EM Brunt CG Janney AM Di Bisceglie BA Neuschwander-Tetri BR Bacon 1999 Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions Am J Gastroenterol 94 2467 2474 1:STN:280: DyaK1MvhtFyisw%3D%3D 10.1111/j.1572-0241.1999.01377.x 10484010 (Pubitemid 29420675)
15. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL Conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-30.
16. Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M. Staging of hepatocellular carcinoma assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg. 2007;245:909-22.
17. HA Edmondson PE Steiner 1954 Primary carcinoma of the liver. A study of 100 cases among 4900 necropsies Cancer 7 462 503 1:STN:280: DyaG2c%2FotV2mtQ%3D%3D 10.1002/1097-0142(195405)7:3<462::AID- CNCR2820070308>3.0.CO;2-E 13160935
18. Y Zen K Katayanagi K Tsuneyama K Harada I Araki Y Nakanuma 2001 Hepatocellular carcinoma arising in non-alcoholic steatohepatitis Pathol Int 51 127 131 1:STN:280:DC%2BD3M3hsVKitw%3D%3D 10.1046/j.1440-1827.2001.01174.x 11169153 (Pubitemid 32174740)
19. H Imamura Y Matsuyama E Tanaka T Ohkubo K Hasegawa S Miyagawa, et al. 2003 Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy J Hepatol 38 200 207 10.1016/S0168-8278(02)00360-4 12547409 (Pubitemid 36169630)
20. M Koda Y Murawaki A Mitsuda K Ohyama Y Horie T Suou, et al. 2000 Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma Cancer 88 529 537 1:STN:280:DC%2BD3c7hsFemtg%3D%3D 10.1002/(SICI)1097-0142(20000201)88:3<529:: AID-CNCR6>3.0.CO;2-M 10649243 (Pubitemid 30056925)
21. Y Sasaki T Yamada H Tanaka H Ohigashi H Eguchi M Yano, et al. 2006 Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma Ann Surg 244 771 780 10.1097/01.sla.0000225126.56483.b3 17060771 (Pubitemid 44629952)
22. H Toyoda T Kumada S Kiriyama Y Sone M Tanikawa Y Hisanaga, et al. 2008 Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma J Gastroenterol Hepatol 23 459 466 10.1111/j.1440-1746. 2007.05138.x 17854425 (Pubitemid 351342069)
23. K Taura I Ikai E Hatano H Fujii N Uyama Y Shimahara 2006 Implication of frequent local ablation therapy for intrahepatic recurrence in prolonged survival of patients with hepatocellular carcinoma undergoing hepatic resection Ann Surg 244 265 273 10.1097/01.sla.0000217921.28563.55 16858190 (Pubitemid 44305542)
24. T Sassa T Kumada S Nakano T Uematsu 1999 Clinical utility of simultaneous measurement of serum high-sensitivity des-gamma-carboxy prothrombin and Lens culinaris agglutinin A-reactive alpha-fetoprotein in patients with small hepatocellular carcinoma J Gastroenterol Hepatol 11 1387 1392 1:CAS:528:DC%2BD3cXhtFSjtrw%3D 10.1097/00042737-199912000-00008
25. H Okuda T Nakanishi K Takatsu A Saito N Hayashi K Takasaki, et al. 2000 Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma Cancer 88 544 549 1:CAS:528:DC%2BD3cXptVakuw%3D%3D 10.1002/(SICI)1097-0142(20000201)88:3<544:: AID-CNCR8>3.0.CO;2-F 10649245 (Pubitemid 30056927)
26. S Caldwell SH Park 2009 The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology J Gastroenterol 44 Suppl 19 96 101 10.1007/s00535-008-2258-6 19148801